
Mirae Secures $5.4M to Bridge Gaps in Chronic Disease Care
Chronic conditions like inflammatory bowel disease currently force patients into a cycle of episodic, reactive care. By securing $5.4 million in a funding round led by Oxford Science Enterprises, the startup Mirae aims to replace that uncertainty with a continuous, AI-driven platform that tracks patient symptoms between clinical visits.


























